(720 ILCS 570/207) (from Ch. 56 1/2, par. 1207) Sec. 207. The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance in Schedule III if it finds that: (1) the substance has a potential for misuse less than the substances listed in Schedule I and II; (2) the substance has currently accepted medical use in treatment in the United States; and (3) misuse of the substance may lead to moderate or low physiological dependence or high psychological dependence. (Source: P.A. 103-881, eff. 1-1-25.)